Skip to main content
. 2012 Sep 21;27(2):253–264. doi: 10.1038/eye.2012.175

Figure 2.

Figure 2

IAC for retinoblastoma. (a, b) Primary IAC showing before (a) and after (b) three cycles of melphalan. (c, d) Secondary IAC following IVC but with recurrence of macular and inferior tumours (c) that responded completely (d) to three cycles of melphalan.